Revolutionizing Clinical Trials with AI Innovations

This chapter explores a London startup's impressive $55 million fundraising achievement aimed at transforming clinical trials through artificial intelligence. It underscores the importance of automation and efficiency in addressing challenges in the biotech sector, responding to the evolving drug discovery landscape.